| Year |
Citation |
Score |
| 2016 |
Corsini B, Aguinagalde L, Ruiz S, Domenech M, Antequera ML, Fenoll A, García P, García E, Yuste J. Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis. Vaccine. PMID 27840016 DOI: 10.1016/j.vaccine.2016.11.001 |
0.53 |
|
| 2015 |
Aguinagalde L, Corsini B, Domenech A, Domenech M, Cámara J, Ardanuy C, García E, Liñares J, Fenoll A, Yuste J. Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response. Plos One. 10: e0137565. PMID 26368279 DOI: 10.1371/journal.pone.0137565 |
0.557 |
|
| 2015 |
Domenech M, Damián D, Ardanuy C, Liñares J, Fenoll A, García E. Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro. Plos One. 10: e0125636. PMID 25927917 DOI: 10.1371/journal.pone.0125636 |
0.559 |
|
| 2015 |
Ardanuy C, de la Campa AG, García E, Fenoll A, Calatayud L, Cercenado E, Pérez-Trallero E, Bouza E, Liñares J. Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain. Emerging Infectious Diseases. 20: 1848-56. PMID 25340616 DOI: 10.3201/eid2011.131215 |
0.607 |
|
| 2011 |
Rolo D, Ardanuy C, Calatayud L, Pallares R, Grau I, García E, Fenoll A, Martín R, Liñares J. Characterization of invasive Pneumococci of serogroup 6 from adults in Barcelona, Spain, in 1994 to 2008. Journal of Clinical Microbiology. 49: 2328-30. PMID 21450964 DOI: 10.1128/JCM.02545-10 |
0.556 |
|
| 2011 |
Tarragó D, Aguilar L, García R, Gimenez MJ, Granizo JJ, Fenoll A. Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008. Antimicrobial Agents and Chemotherapy. 55: 2297-302. PMID 21343456 DOI: 10.1128/AAC.01494-10 |
0.406 |
|
| 2006 |
Fenoll A, Giménez MJ, Robledo O, Coronel P, Gimeno M, Casal J, Aguilar L. Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones. International Journal of Antimicrobial Agents. 29: 224-6. PMID 17175141 DOI: 10.1016/j.ijantimicag.2006.08.046 |
0.309 |
|
| 2006 |
Balsalobre L, Hernández-Madrid A, Llull D, Martín-Galiano AJ, García E, Fenoll A, de la Campa AG. Molecular characterization of disease-associated streptococci of the mitis group that are optochin susceptible. Journal of Clinical Microbiology. 44: 4163-71. PMID 16971639 DOI: 10.1128/JCM.01137-06 |
0.56 |
|
| 2006 |
Marimón JM, Pérez-Trallero E, Ercibengoa M, Gonzalez A, Fenoll A. Molecular epidemiology and variants of the multidrug-resistant Streptococcus pneumoniae Spain14-5 international clone among Spanish clinical isolates. The Journal of Antimicrobial Chemotherapy. 57: 654-60. PMID 16484341 DOI: 10.1093/jac/dkl028 |
0.306 |
|
| 2003 |
Jado I, López R, García E, Fenoll A, Casal J, García P. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. The Journal of Antimicrobial Chemotherapy. 52: 967-73. PMID 14613958 DOI: 10.1093/jac/dkg485 |
0.512 |
|
| 2002 |
Obregón V, García P, García E, Fenoll A, López R, García JL. Molecular peculiarities of the lytA gene isolated from clinical pneumococcal strains that are bile insoluble. Journal of Clinical Microbiology. 40: 2545-54. PMID 12089276 DOI: 10.1128/Jcm.40.7.2545-2554.2002 |
0.56 |
|
| Show low-probability matches. |